WinMedica, headquartered in Athens, Greece, is on a mission to enhance patient care and elevate the quality of life within our community. We are engaged in all significant therapeutic sectors, including: Cardiovascular Oncology Central Nervous System Rare Diseases Our collaboration extends to leading pharmaceutical companies worldwide, ensuring that we address the medical needs of patients. Presently, WinMedica is in the process of establishing its first manufacturing facility in Tripoli, Greece, with a primary focus on treatments for Oncology.